Allogene stock price

Author: scnr

August undefined, 2024

WebALLO - Stock quote for ALLOGENE THERAPEUTICS, INC. - MSN Money. September 2, 2024 4:37 PM EDT. Delayed 15 minutes; NASDAQ. Currency In USD. Market Cap. WebApr 13, 2024 · The company’s stock has been forecasted to trade at an average price of $16.65 over the course of the next 52 weeks, with a low of $6.00 and a high of $35.00. Based on these price targets, the low is -30.72% off current price, whereas the price has to move -662.53% to reach the yearly target high.

Wall Street Analysts Think Allogene Therapeutics (ALLO) Could …

WebNews Allogene Therapeutics Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-2.32 Market Cap $823.64 M Shares Outstanding 144.50 M Public Float... WebAllogene Therapeutics, Inc. Common Stock (ALLO) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. lyre d\u0027apollon assassin\u0027s creed odyssey

ALLO Allogene Therapeutics Inc. Stock Price & News - WSJ

WebFeb 21, 2024 · SOUTH SAN FRANCISCO, Calif. , March 02, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, today announced that it will participate in two upcoming investor Mar 01, 2024 WebMar 30, 2024 · Allogene had $576.5 million of cash, cash equivalents and investments as of Dec 31, 2024, compared with $637.3 million as of Sep 30, 2024. 2024 Guidance Allogene anticipates operating expenses... kirby buckets wikipedia

ALLO Price Target 2024 Allogene Therapeutics Analyst Ratings

Allogene Therapeutics, Inc. (ALLO) - Yahoo!

WebApr 13, 2024 · Allogene Therapeutics ... Their average price target comes out to $18.71, implying nearly 308% upside potential. ... the market doesn’t see it that way. Since the … WebAllogene Therapeutics Inc (ALLO) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. ... What is Allogene Therapeutics Inc(ALLO)'s stock price today? The current price of ALLO is $5.07. The 52 week high of ALLO is $17.49 and 52 week low is $4.42. ly referral\u0027sWebALLO Stock 12 Months Forecast. $17.46. (218.03% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Allogene Therapeutics in the last 3 months. … ly referral\\u0027s

"WebApr 14, 2024 · Get a technical analysis of Allogene Therapeutics Inc (ALLO) with the latest MACD of -0.37 and RSI of 29.49. Stay up-to-date on market trends with our expert analysis. ... (ALLO) stock price is $5.05 and Allogene Therapeutics Inc ’s (ALLO) 100-day simple moving average is 6.89, creating a Sell signal. " - Allogene stock price

Allogene stock price

Allogene Therapeutics Inc. (NASDAQ: ALLO): Making Its Way Up The St…

WebAllogene Therapeutics has raised a total of $531.8M in funding over 2 rounds. Their latest funding was raised on Sep 7, ... IPO & Stock Price. Edit IPO & Stock Price Section. Allogene Therapeutics is registered under the ticker NASDAQ:ALLO . Their stock opened with $18.00 in its Oct 11, 2024 IPO. WebAllogene Therapeutics Inc. $5.05. ALLO 10.02%. Stem Inc. $5.10. STEM 1.59%. Silvergate Capital Corp. ... A valuation method that multiplies the price of a company's stock by the total number of ...

Did you know?

WebApr 12, 2024 · According to 27 analysts, the average rating for ALLO stock is "Buy." The 12-month stock price forecast is $18.06, which is an increase of 293.46% from the latest … WebApr 11, 2024 · Allogene Therapeutics Inc. (ALLO) is priced at $4.53 after the most recent trading session. Allogene Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $17.49 on 08/12/22, with the lowest value was $4.42 for

WebMar 24, 2024 · Allogene Therapeutics, Inc. ( NASDAQ:ALLO – Get Rating )’s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $5.20 and last traded at $5.28, with a volume of 268912 shares changing hands. The stock had previously closed at $5.36. Analysts Set New Price Targets WebApr 10, 2024 · The trading price of Allogene Therapeutics Inc. (NASDAQ:ALLO) closed lower on Thursday, April 06, closing at $4.89, -1.01% lower than its previous close. ... In examining the 52-week price action we see that the stock hit a 52-week high of $17.49 and a 52-week low of $4.72. Over the past month, the stock has lost -19.31% in value. ...

WebApr 11, 2024 · ALLO Allogene Therapeutics, Inc.Stock Price & Overview. $5.11 0.19 ( +3.86%) 4:00 PM 03/29/23. NASDAQ $USD Post-Market: $5.14 +0.03 (+0.59%) 7:54 … WebApr 12, 2024 · Allogene Therapeutics stock was originally listed at a price of $25.00 in Oct 11, 2024. If you had invested in Allogene Therapeutics stock at $25.00, your return over …

WebSOUTH SAN FRANCISCO, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, today announced that it will participate in four upcoming investor conferences. Canaccord Genuity - CG …

WebGet Allogene Therapeutics Inc (ALLO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. kirby buckets warpedWebApr 12, 2024 · ALLO Stock Overview. Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T … lyre exchange rateWebOct 6, 2024 · SOUTH SAN FRANCISCO, Calif., Oct. 06, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, today announced the initiation of the potentially pivotal Phase 2 clinical trial of ALLO-501A … ly referent\\u0027sWeb1 day ago · Allogene Therapeutics, Inc. SOUTH SAN FRANCISCO, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the ... kirby buildingWeb1 day ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Allogene Therapeutics (ALLO) ... (ALLO) Quote Overview » Charts » Allogene Therapeutics (ALLO ... ly reflector\\u0027sWebWall Street Stock Market & Finance report, prediction for the future: You'll find the Allogene Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Allogene Therapeutics's ALLO shares and potentially its market environment have been in bearish cycle last 12 months (if exists). lyre emoji copy and pasteWebApr 11, 2024 · Allogene Therapeutics Inc. (ALLO) is priced at $4.53 after the most recent trading session. Allogene Therapeutics Inc. had a pretty Dodgy run when it comes to the … ly referent\u0027s